RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Takashi Matsui to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Takashi Matsui has written about Protein Kinase Inhibitors.
Takashi Matsui
Connection Strength
0.039
Protein Kinase Inhibitors
  1. Oya Y, Yoshida T, Asada K, Oguri T, Inui N, Morikawa S, Ito K, Kimura T, Kunii E, Matsui T, Kubo A, Kato T, Abe T, Tsuda T, Hida T. Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib. BMC Cancer. 2021 Jan 12; 21(1):57.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support